Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Get Free Report) EVP Nathan Brower sold 3,800 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $20.81, for a total transaction of $79,078.00. Following the transaction, the executive vice president owned 46,735 shares of the company’s stock, valued at $972,555.35. This trade represents a 7.52% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Nature’s Sunshine Products Price Performance
Shares of NATR traded up $0.29 during midday trading on Tuesday, reaching $20.82. The stock had a trading volume of 104,898 shares, compared to its average volume of 79,336. The company has a market cap of $364.27 million, a price-to-earnings ratio of 28.14 and a beta of 1.09. The company’s fifty day simple moving average is $15.85 and its two-hundred day simple moving average is $15.41. Nature’s Sunshine Products, Inc. has a 1-year low of $11.01 and a 1-year high of $21.64.
Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) last posted its earnings results on Thursday, November 6th. The company reported $0.36 EPS for the quarter, beating the consensus estimate of $0.18 by $0.18. Nature’s Sunshine Products had a return on equity of 10.19% and a net margin of 3.06%.The firm had revenue of $88.99 million for the quarter, compared to analyst estimates of $119.39 million. Nature’s Sunshine Products has set its FY 2025 guidance at EPS.
Hedge Funds Weigh In On Nature’s Sunshine Products
Wall Street Analyst Weigh In
NATR has been the subject of several recent analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Nature’s Sunshine Products in a research note on Wednesday, October 8th. DA Davidson upped their target price on shares of Nature’s Sunshine Products from $21.00 to $23.00 and gave the company a “buy” rating in a report on Monday, November 10th. Finally, Canaccord Genuity Group lifted their price target on shares of Nature’s Sunshine Products from $21.00 to $22.00 and gave the stock a “buy” rating in a research note on Friday, August 1st. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Nature’s Sunshine Products currently has an average rating of “Moderate Buy” and a consensus target price of $22.50.
View Our Latest Stock Analysis on NATR
Nature’s Sunshine Products Company Profile
Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Read More
- Five stocks we like better than Nature’s Sunshine Products
- Investing in the High PE Growth Stocks
- What’s on the Thanksgiving Table? A Stock Pick for Every Course
- What Is WallStreetBets and What Stocks Are They Targeting?
- Why Home Depot’s Pain Could Be a Long-Term Investor’s Gain
- How to Buy Gold Stock and Invest in Gold
- Qualcomm’s Bulls Are Running Out of Room to Be Wrong
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.
